← Back

Wire · opportunities

Cubresa Announces FDA 510(k) Clearance for the Cubresa BrainPET™ Scanner, Opening ...

Published

21 August 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at advamed.org

Verified

Fusion42 · 21 August 2026 · Fusion42 review

Cubresa received FDA 510(k) clearance for its BrainPET scanner, a device that retrofits into existing Siemens Biograph mMR systems enabling simultaneous PET/MR brain imaging without the expense of standalone scanners. This advances access to high-resolution molecular and anatomical brain imaging for neurological diagnostics.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ The Wire takeaway

You can now position your neuroimaging solutions as accessible upgrades rather than costly replacements. This FDA clearance removes a major capital barrier for hospitals expanding brain imaging, opening fast clinical adoption routes.

Coverage

1 source · 21 Aug 2026

Related on Wire

Topics

Medtechfda-clearancebrain-imagingmedical-deviceneuroimagingclinical-tech